Wuxi Biologics Placement - This Time It's Different
Wuxi Biologics (Cayman) Inc (2269 HK) is looking to raise around US$660m in a primary placement. This is in contrast to the nine other placement...
456 Views
ECM Weekly (24 May 2020) - NetEase and JD Homecoming, Legend Biotech, Nongfu Spring, Yeahka
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. The talk...
215 Views
Wuxi Biologics Placement - Biggest Deal Size at Launch, Well Ahead of Lock-Up Expiry
Wuxi Biologics Holdings is looking to raise up to US$826m by selling 3.8% of Wuxi Biologics (Cayman) Inc (2269 HK). This will be ninth placement by...
310 Views
China Health Care - Allocation Boom: Wuxi Biologics/Jinyu Bio-Tech/Hangzhou Tigermed Top Picks
With increased focus on the Health Care sector in light of the COVID-19 pandemic, Health Care allocations reached record levels last month. We...
311 Views
EM Strategy and Chartbook: Remain Overweight EM Vs. EAFE
China (MSCI China, Shanghai Comp., Shenzhen A Share) continues to offer many attractive setups and is a major focus in today’s EM Strategy report....
315 Views